Product Information

PRAVASTATIN SODIUM 80 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.1365 per EA under NDC 69097079212. Its NADAC has been published 98 times since Jan 1, 2025.

FDA first approved this application on May 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAVASTATIN SODIUM 80 MG TAB

PRAVASTATIN SODIUM
$0.1365per EA

Strength

80 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097079212

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PRAVASTATIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA077987

FDA Approved

5/11/2007

TE Code

AB

On Market Since

6/1/2024

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PRAVASTATIN SODIUM 80 MG TAB has been published 98 times since Jan 1, 2025, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1365 per EA
All-time high$0.1652 (Apr 16, 2025)
All-time low$0.1365 (Oct 21, 2026)
52-week high$0.1603
52-week low$0.1365
Median price$0.1569
Average price$0.1544
Largest weekly change+10.8% (Feb 19, 2025)
Weeks tracked98
Tracking sinceJan 1, 2025

Price History

1W

0.0%

1M

-4.8%

3M

-8.5%

6M

-8.4%

1Y

-14.6%

3Y

N/A

5Y

N/A

All

-4.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRAVASTATIN SODIUM 80 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for PRAVASTATIN SODIUM 80 MG TAB, manufactured by Cipla USA Inc., is $0.1365 per EA (NDC 69097079212), effective Nov 11, 2026.

How has the price of PRAVASTATIN SODIUM 80 MG TAB changed over time?

Over the history we have for it, the NADAC for PRAVASTATIN SODIUM 80 MG TAB has declined 4.3%. It has been tracked across 98 weekly CMS publications since Jan 1, 2025.

What are the highest and lowest recorded NADAC prices for PRAVASTATIN SODIUM 80 MG TAB?

Since Jan 1, 2025, the NADAC for PRAVASTATIN SODIUM 80 MG TAB has ranged from a low of $0.1365 (Oct 21, 2026) to a high of $0.1652 (Apr 16, 2025), with a median of $0.1569 per EA.

Are there cheaper alternatives to PRAVASTATIN SODIUM 80 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAVASTATIN SODIUM 80 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures PRAVASTATIN SODIUM 80 MG TAB?

PRAVASTATIN SODIUM 80 MG TAB (NDC 69097079212) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.